{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:24:29Z","timestamp":1771676669000,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1989,3,1]],"date-time":"1989-03-01T00:00:00Z","timestamp":604713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1989,3]]},"DOI":"10.1007\/bf01806524","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T19:38:26Z","timestamp":1119901106000},"page":"123-133","source":"Crossref","is-referenced-by-count":78,"title":["Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases"],"prefix":"10.1007","volume":"13","author":[{"given":"Ram\u00f3n","family":"Colomer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Ruibal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Genoll\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Del Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Bodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01806524_CR1","first-page":"986","volume":"31","author":"R Tobias","year":"1985","unstructured":"Tobias R, Rothwell C, Wagner J, Green A, Liu Y-SV: Development and evaluation of a radioimmunoassay for the detection of a monoclonal antibody defined breast tumor associated antigen 115D8\/DF3 (abstract). Clin Chem 31: 986, 1985","journal-title":"Clin Chem"},{"key":"BF01806524_CR2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1200\/JCO.1986.4.10.1542","volume":"4","author":"DF Hayes","year":"1986","unstructured":"Hayes DF, Zurawski VR, Kufe DW: Comparison of circulating CA 15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol 4: 1542\u20131550, 1986","journal-title":"J Clin Oncol"},{"key":"BF01806524_CR3","first-page":"20","volume":"7","author":"R Colomer","year":"1988","unstructured":"Colomer R, Lianes P, Ruibal A, Cortes-Funes H, Salvador L, Hornedo J: Circulating CA 15-3 levels in patients with breast cancer predict relapse and correlate with metastatic tumor burden (abstract). Proceedings Am Soc Clin Oncol 7: 20, 1988","journal-title":"Proceedings Am Soc Clin Oncol"},{"key":"BF01806524_CR4","first-page":"167","volume-title":"Clinical Relevance of New Monoclonal Antibodies","author":"W J\u00e4ger","year":"1986","unstructured":"J\u00e4ger W, Wildt L, Leyendecker G: CA 15\/3 and CEA serum concentrations in breast cancer patients. In: Greten H, Klapdor R (eds.) Clinical Relevance of New Monoclonal Antibodies. Georg Thieme Verlag, Stuttgart, 1986, pp 167\u2013173"},{"key":"BF01806524_CR5","first-page":"85","volume":"7","author":"R Paulick","year":"1986","unstructured":"Paulick R, Caffier H, Kaesemann H: Erste erfahrungen mit dem monoklonalen markersystem CA 15-3 bei mammakarzinompatientinnen. Tumor Diagn Ther 7: 85\u201387, 1986","journal-title":"Tumor Diagn Ther"},{"key":"BF01806524_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/bjc.1987.115","volume":"55","author":"DMF Pons-Anicet","year":"1987","unstructured":"Pons-Anicet DMF, Krebs BP, Mira R, Namer M: Value of CA 15:3 in the follow-up of breast cancer patients. Br J Cancer 55: 567\u2013569, 1987","journal-title":"Br J Cancer"},{"key":"BF01806524_CR7","first-page":"2310","volume":"14","author":"M Yoshimoto","year":"1987","unstructured":"Yoshimoto M, Akiyama F, Watanabe S, Kasumi F, Fukami A, Nakajima T, Nishi M, Kajitani T, Takahashi S: Estimates of circulating breast cancer-associated antigen CA 15-3 as a monitoring marker in patients with breast cancer. Gan To Kagayu Ryoho 14: 2310\u20132315, 1987","journal-title":"Gan To Kagayu Ryoho"},{"key":"BF01806524_CR8","unstructured":"Paladini G, Capelli M, Rivelli D, Plate L, Carmentano P, Bianchi D: CA 15-3 e carcinoma della mammella: considerazioni preliminari (abstract). Proceedings XI Congr Nazionale di Oncologia 1985; 342"},{"key":"BF01806524_CR9","first-page":"70","volume-title":"New Tumor Markers and their Monoclonal Antibodies","author":"G Sturm","year":"1987","unstructured":"Sturm G, Schmidt-Rhode P, Schulz K-D, Frick M, Schulz U: The diagnostic value of the CA 15-3 determination in the post-care of breast cancer patients: first results of a prospective study. In: Klapdor R (ed) New Tumor Markers and their Monoclonal Antibodies. Georg Thieme Verlag, Stuttgart, 1987, pp 70\u201373"},{"key":"BF01806524_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/172460088600100204","volume":"1","author":"M Tommasi","year":"1986","unstructured":"Tommasi M, Fantappie B, Distante V, Cataliotti L, Neri B, Ciatto S, Pacini P: The role of a new monoclonal antibody assay in the detection of recurrent breast cancer. Int J Biol Markers 1: 81\u201384, 1986","journal-title":"Int J Biol Markers"},{"key":"BF01806524_CR11","first-page":"476","volume":"88","author":"A Ruibal","year":"1987","unstructured":"Ruibal A, Genolla J, Rosell M, Moragas M: El CA 15-3-ELSA serio en patologias no tumorales (letter). Med Clin (Barc) 88: 476, 1987","journal-title":"Med Clin (Barc)"},{"key":"BF01806524_CR12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/bjc.1987.297","volume":"56","author":"NMP Sacks","year":"1987","unstructured":"Sacks NMP, Stacker SA, Thompson CH, Collins JP, Russell IS, Sullivan JA, McKenzie IFC: Comparison of mammary serum antigen (MSA) and CA 15-3 levels in the serum of patients with breast cancer. Br J Cancer 56: 820\u2013824, 1987","journal-title":"Br J Cancer"},{"key":"BF01806524_CR13","first-page":"46","volume-title":"New Tumor Markers and their Monoclonal Antibodies","author":"P Stieber","year":"1987","unstructured":"Stieber P, Diergarten K, Eiermann W, Albiez M, Fateh-Moghadam A: CA 15-3: evaluation and clinical value in breast carcinomas compared with CEA and TPA. In: Klapdor R (ed) New Tumor Markers and their Monoclonal Antibodies. Georg Thieme Verlag, Stuttgart, 1987, pp 46\u201351"},{"key":"BF01806524_CR14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ijc.2910340210","volume":"34","author":"J Hilkens","year":"1984","unstructured":"Hilkens J, Buijs F, Hilgers J, Hageman P, Calafat J, Sonnenberg A, van de Valk M: Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 34: 197\u2013206, 1984","journal-title":"Int J Cancer"},{"key":"BF01806524_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/hyb.1984.3.223","volume":"3","author":"D Kufe","year":"1984","unstructured":"Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J: Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3: 223\u2013232, 1984","journal-title":"Hybridoma"},{"key":"BF01806524_CR16","first-page":"97","volume-title":"New Tumor Markers and their Monoclonal Antibodies","author":"Y Ochi","year":"1987","unstructured":"Ochi Y, Okabe H, Imokawa M: Antigen detection by the monoclonal antibodies CA 19-9, CA 125, and CA 15-3 in serum and body fluid of cancer and non-cancerous state. In: Klapdor R (ed) New Tumor Markers and their Monoclonal Antibodies. Georg Thieme Verlag, Stuttgart, 1987, pp 97\u2013104"},{"key":"BF01806524_CR17","first-page":"342","volume-title":"New Tumor Markers and Their Monoclonal Antibodies","author":"M Gion","year":"1987","unstructured":"Gion M, Mione R, Dittadi R, Zari C, Bruscagnin G: CA 15-3 in breast cancer tissue. In: Klapdor R (ed) New Tumor Markers and Their Monoclonal Antibodies. Georg Thieme Verlag, Stuttgart, 1987, pp 342\u2013347"},{"key":"BF01806524_CR18","first-page":"1126","volume":"32","author":"P Vendely","year":"1986","unstructured":"Vendely P, Pandian MR: Correlation of a mammary tumor associated antigen (CA 15-3) with steroid receptors in human mammary tumor extracts (abstract). Clin Chem 32: 1126, 1986","journal-title":"Clin Chem"},{"key":"BF01806524_CR19","first-page":"180","volume":"28","author":"LL Schenken","year":"1987","unstructured":"Schenken LL, Pugh RP, Schmidt DM, Grden MA, Zidar BL: Antigen expression and steroid receptor status within human breast tumors (abstract). Proc Am Assoc Cancer Res 28: 180, 1987","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF01806524_CR20","doi-asserted-by":"crossref","unstructured":"Colomer R, Ruibal A, Genoll\u00e1 J, Salvador L: Circulating CA 15-3 antigen levels in patients with non-mammary malignancies. Br J Cancer 59, 1989 (in press)","DOI":"10.1038\/bjc.1989.58"},{"key":"BF01806524_CR21","first-page":"57","volume-title":"New Tumor Markers and their Monoclonal Antibodies","author":"GP Breitbach","year":"1987","unstructured":"Breitbach GP, Kaul S, Behnken LJ, Wieser N, Altholz H, Bastert G: Tumour marker concentration in blood sera of patients with extended breast cancer in relation to metastatic localisation and tumour mass. In: Klapdor R (ed) New Tumor Markers and their Monoclonal Antibodies. Georg Thieme Verlag, Stuttgart, 1987, pp 57\u201357"},{"key":"BF01806524_CR22","first-page":"113","volume-title":"New Tumor Markers and their Monoclonal Antibodies","author":"G Ingersleben","year":"1987","unstructured":"Ingersleben G, Souchon R, Brand U, Fitzner R: CA 15-3 in comparison with CEA in the follow-up and therapy control of breast carcinoma: new aspects. In: Klapdor R (ed) New Tumor Markers and their Monoclonal Antibodies. Georg Thieme Verlag, Stuttgart, 1987, pp 113\u2013117"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806524\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:43:56Z","timestamp":1557402236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989,3]]}},"alternative-id":["BF01806524"],"URL":"https:\/\/doi.org\/10.1007\/bf01806524","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,3]]}}}